{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:18:10Z","timestamp":1760955490939},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/internalmedicine.53.1829","type":"journal-article","created":{"date-parts":[[2014,7,14]],"date-time":"2014-07-14T23:12:13Z","timestamp":1405379533000},"page":"1523-1526","source":"Crossref","is-referenced-by-count":24,"title":["Long-term Pharmacological Therapy of Brugada Syndrome: Is J-wave Attenuation a Marker of Drug Efficacy?"],"prefix":"10.2169","volume":"53","author":[{"given":"Kanae","family":"Hasegawa","sequence":"first","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Japan"},{"name":"Department of Cardiovascular Biology and Medicine, Niigata University School of Medical and Dental Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ashihara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikari","family":"Jo","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Itoh","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifusa","family":"Aizawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Niigata University School of Medical and Dental Sciences, Japan"},{"name":"Division of Research and Development, Tachikawa Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Horie","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Antzelevitch C. Genetic, molecular and cellular mechanisms underlying the J wave syndromes. Circ J 76: 1054-1065, 2012.","DOI":"10.1253\/circj.CJ-12-0284"},{"key":"2","unstructured":"2. Shu J, Zhu T, Yang L, Cui C, Yan GX. ST-segment elevation in the early repolarization syndrome, idiopathic ventricular fibrillation, and the Brugada syndrome: cellular and clinical linkage. J Electrocardiol 38: 26-32, 2005."},{"key":"3","unstructured":"3. Haissaguerre M, Derval N, Sacher F, et al. Sudden cardiac arrest associated with early repolarization. N Engl J Med 358: 2016-2023, 2008."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nam GB, Kim YH, Antzelevitch C. Augmentation of J waves and electrical storms in patients with early repolarization. N Engl J Med 358: 2078-2079, 2008.","DOI":"10.1056\/NEJMc0708182"},{"key":"5","unstructured":"5. Haissaguerre M, Sacher F, Nogami A, et al. Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. J Am Coll Cardiol 53: 612-619, 2009."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Aizawa Y, Chinushi M, Hasegawa K, et al. Electrical storm in idiopathic ventricular fibrillation is associated with early repolarization. J Am Coll Cardiol 62: 1015-1019, 2013.","DOI":"10.1016\/j.jacc.2013.05.030"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Belhassen B, Glick A, Viskin S. Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome. Pacing Clin Electrophysiol 32: 294-301, 2009.","DOI":"10.1111\/j.1540-8159.2008.02235.x"},{"key":"8","unstructured":"8. Viskin S, Antzelevitch C, Marquez MF, Belhassen B. Quinidine: a valuable medication joins the list of 'endangered species'. Europace 9: 1105-1106, 2007."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tsuchiya T, Ashikaga K, Honda T, Arita M. Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 13: 698-701, 2002.","DOI":"10.1046\/j.1540-8167.2002.00698.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Iguchi K, Noda T, Kamakura S, Shimizu W. Beneficial effects of cilostazol in a patient with recurrent ventricular fibrillation associated with early repolarization syndrome. Heart Rhythm 10: 604-606, 2013.","DOI":"10.1016\/j.hrthm.2012.11.001"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Aizawa Y, Sato A, Watanabe H, et al. Dynamicity of the J-wave in idiopathic ventricular fibrillation with a special reference to pause-dependent augmentation of the J-wave. J Am Coll Cardiol 59: 1948-1953, 2012.","DOI":"10.1016\/j.jacc.2012.02.028"},{"key":"12","unstructured":"12. Chinushi M, Hasegawa K, Iijima K, et al. Characteristics of J wave-associated idiopathic ventricular fibrillation: role of drugs. Pacing Clin Electrophysiol 35: e226-e230, 2012."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ohgo T, Okamura H, Noda T, et al. Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation. Heart Rhythm 4: 695-700, 2007.","DOI":"10.1016\/j.hrthm.2007.02.014"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kamakura S, Ohe T, Nakazawa K, et al. Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3. Circ Arrhythm Electrophysiol 2: 495-503, 2009.","DOI":"10.1161\/CIRCEP.108.816892"},{"key":"15","unstructured":"15. Kawata H, Morita H, Yamada Y, et al. Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: a novel risk factor for Brugada syndrome with ventricular fibrillation. Heart Rhythm 10: 1161-1168, 2013."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/14\/53_53.1829\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:51:25Z","timestamp":1621446685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/14\/53_53.1829\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":15,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.53.1829","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}